Literature DB >> 17429737

Levels of hepatitis B virus (HBV) replication during the nonreplicative phase: HBV quantification by real-time PCR in Korea.

Hyung Joon Yim1, Kwan Soo Byun, Yun Jung Chang, Yeon Seok Suh, Jong Eun Yeon, Chang Hong Lee, Jung Ah Kwon, Wangdon Yoo, Soo-Ok Kim, Sun Pyo Hong.   

Abstract

The levels of HBV replication in the nonreplicative phase are not clear. We conducted this study to evaluate the levels of viral replication during the nonreplicative phase in chronic HBV-infected Korean patients using real-time PCR. A total of 125 patients were classified into three groups: inactive HBsAg carriers, inactive liver cirrhosis patients, and resolved chronic HBV-infected patients with loss of HBsAg. The real-time PCR detected HBV DNA in 112 cases (89.6%). The mean levels of HBV DNA were 3.84, 4.10, and 3.31 log copies/ml in the three groups, respectively (P <0.01). Ninety-five percent of inactive HBsAg carriers showed levels of HBV DNA lower than 6 x 10(4) copies/ml. In conclusion, we showed different levels of HBV DNA exactly in three groups during nonreplicative phases. We suggest that the cutoff level of HBV DNA in inactive HBsAg carriers should be readjusted to a lower level in future studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17429737     DOI: 10.1007/s10620-006-9140-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

1.  Hepatitis B virus genotypes in Korea: an endemic area of hepatitis B virus infection.

Authors:  Byung-Cheol Song; Xiu Ji Cui; Heung Kim
Journal:  Intervirology       Date:  2005       Impact factor: 1.763

Review 2.  Diagnosis and management of pre-core mutant chronic hepatitis B.

Authors:  G V Papatheodoridis; S J Hadziyannis
Journal:  J Viral Hepat       Date:  2001-09       Impact factor: 3.728

3.  Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B.

Authors:  M Lindh; P Horal; A P Dhillon; G Norkrans
Journal:  J Viral Hepat       Date:  2000-07       Impact factor: 3.728

4.  Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes.

Authors:  Helene Norder; Anne-Marie Couroucé; Pierre Coursaget; José M Echevarria; Shou-Dong Lee; Isa K Mushahwar; Betty H Robertson; Stephen Locarnini; Lars O Magnius
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

5.  Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter.

Authors:  Vaishali Chaudhuri; Ruchi Tayal; Baibaswata Nayak; Subrat Kumar Acharya; Subrat Kumar Panda
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted.

Authors:  M J Gandhi; G G Yang; B J McMahon; G N Vyas
Journal:  Transfusion       Date:  2000-08       Impact factor: 3.157

7.  Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection.

Authors:  Yi-Cheng Chen; I-Shyan Sheen; Chia-Ming Chu; Yun-Fan Liaw
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

8.  HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

Authors:  Man-Fung Yuen; Danny Ka-Ho Wong; Erwin Sablon; Eric Tse; Irene Oi-Lin Ng; He-Jun Yuan; Chung-Wah Siu; Tamara J Sander; Eric J Bourne; Jeff G Hall; Lynn D Condreay; Ching-Lung Lai
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

9.  Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.

Authors:  T I Huo; J C Wu; P C Lee; G Y Chau; W Y Lui; S H Tsay; L T Ting; F Y Chang; S D Lee
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

10.  Rapid detection and quantitation of hepatitis B virus DNA by real-time PCR using a new fluorescent (FRET) detection system.

Authors:  Sani Hussein Aliyu; Muktar Hassan Aliyu; Hamisu M Salihu; Surendra Parmar; Hamid Jalal; Martin David Curran
Journal:  J Clin Virol       Date:  2004-06       Impact factor: 3.168

View more
  3 in total

1.  Performance evaluation of TRUPCR® HBV Real-time PCR assay for Hepatitis B virus DNA quantification in clinical samples: report from a tertiary care liver centre.

Authors:  Sujata Lall; Manish C Choudhary; Supriya Mahajan; Guresh Kumar; Ekta Gupta
Journal:  Virusdisease       Date:  2019-01-05

2.  Comparison of real-time polymerase chain reaction with the COBAS Amplicor test for quantitation of hepatitis B virus DNA in serum samples.

Authors:  Ming Shi; Yong Zhang; Ying-Hua Zhu; Jing Zhang; Wei-Jia Xu
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

3.  Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB.

Authors:  Shao-hang Cai; Fang-fang Lv; Yong-hong Zhang; Ye-gui Jiang; Jie Peng
Journal:  BMC Infect Dis       Date:  2014-02-14       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.